BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36692642)

  • 1. The prognostic values of FOXP3
    Sun Y; Wang Y; Lu F; Zhao X; Nie Z; He B
    Clin Transl Oncol; 2023 Jun; 25(6):1830-1843. PubMed ID: 36692642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial Distribution and Densities of CD103+ and FoxP3+ Tumor Infiltrating Lymphocytes by Digital Analysis for Outcome Prediction in Breast Cancer.
    Chan R; Aphivatanasiri C; Poon IK; Tsang JY; Ni Y; Lacambra M; Li J; Lee C; Tse GM
    Oncologist; 2024 Mar; 29(3):e299-e308. PubMed ID: 37491001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of stromal tumor-infiltrating lymphocytes in patients with breast cancer treated with neoadjuvant chemotherapy: A meta-analysis.
    Xia G; Zhang Z; Jiang Q; Wang H; Wang J
    Medicine (Baltimore); 2024 Feb; 103(6):e36810. PubMed ID: 38335394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    Kawada T; Yanagisawa T; Rajwa P; Motlagh RS; Mostafaei H; Quhal F; Laukhtina E; Pallauf M; König F; Pradere B; Araki M; Nasu Y; Shariat SF
    Clin Genitourin Cancer; 2024 Apr; 22(2):535-543.e4. PubMed ID: 38336572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and predictive value of tumor-infiltrating lymphocytes in breast cancer: a systematic review and meta-analysis.
    Yu X; Zhang Z; Wang Z; Wu P; Qiu F; Huang J
    Clin Transl Oncol; 2016 May; 18(5):497-506. PubMed ID: 26459255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An increase in tumor-infiltrating lymphocytes after treatment is significantly associated with a poor response to neoadjuvant endocrine therapy for estrogen receptor-positive/HER2-negative breast cancers.
    Fukui R; Watanabe T; Morimoto K; Fujimoto Y; Nagahashi M; Ishikawa E; Hirota S; Miyoshi Y
    Breast Cancer; 2023 Sep; 30(5):703-713. PubMed ID: 37115435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis.
    Lee JS; Won HS; Sun S; Hong JH; Ko YH
    Medicine (Baltimore); 2018 Aug; 97(32):e11769. PubMed ID: 30095632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of FOXP3
    Bai Y; He T; Zhang L; Liu Q; Yang J; Zhao Z; Yang K; Zhang M
    BMJ Open; 2022 Sep; 12(9):e060659. PubMed ID: 36691128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between high ratios of CD4/FOXP3 and CD8/CD163 and the improved survivability of metastatic triple-negative breast cancer patients: a multicenter cohort study.
    Tenggara JB; Rachman A; Prihartono J; Rachmadi L; Panigoro SS; Heriyanto DS; Sutandyo N; Nasution IR; Rahadiati FB; Steven R; Betsy R; Juanputra S; Sudoyo AW
    BMC Res Notes; 2024 Feb; 17(1):44. PubMed ID: 38308298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor infiltrating lymphocytes (TILs) are a prognosis biomarker in Colombian patients with triple negative breast cancer.
    Huertas-Caro CA; Ramírez MA; Rey-Vargas L; Bejarano-Rivera LM; Ballen DF; Nuñez M; Mejía JC; Sua-Villegas LF; Cock-Rada A; Zabaleta J; Fejerman L; Sanabria-Salas MC; Serrano-Gomez SJ
    Sci Rep; 2023 Dec; 13(1):21324. PubMed ID: 38044375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of Forkhead box P3 regulatory T cells in biliary tract cancer: A systematic review and meta-analysis.
    Cai P; Wu Z; Yang X; Wang N; Yang Y
    Medicine (Baltimore); 2023 Dec; 102(50):e36608. PubMed ID: 38115302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXP3: A Player of Immunogenetic Architecture in Lung Cancer.
    Ziółkowska-Suchanek I; Żurawek M
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the significance of Foxp3 + tumor-infiltrating lymphocytes in squamous cell lung cancer.
    Shiomi K; Ichinoe M; Ushiwata A; Eshima K; Nagashio R; Hayashi S; Sonoda D; Kondo Y; Maruyama R; Mikubo M; Murakumo Y; Satoh Y
    Clin Transl Oncol; 2024 Feb; ():. PubMed ID: 38402536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Peritumoral CD8 + /FOXP3 + Cell Ratio Has Prognostic Value in Triple-negative Breast Cancer.
    Aldrees R; Siegal GP; Wei S
    Appl Immunohistochem Mol Morphol; 2023 Oct; 31(9):621-628. PubMed ID: 37615661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Immune Microenvironment in Inflammatory Breast Cancer Using Multiplex Immunofluorescence.
    Badr NM; McMurray JL; Danial I; Hayward S; Asaad NY; Abd El-Wahed MM; Abdou AG; Serag El-Dien MM; Sharma N; Horimoto Y; Sircar T; Vidya R; Hoar F; Rea D; Jones JL; Stevens A; Spooner D; Merard R; Lewis P; Hunter KJ; Berditchevski F; Shaaban AM
    Pathobiology; 2023; 90(1):31-43. PubMed ID: 35705026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating immune cells and prognosis in gastric cancer: a systematic review and meta-analysis.
    Jiang W; Liu K; Guo Q; Cheng J; Shen L; Cao Y; Wu J; Shi J; Cao H; Liu B; Tao K; Wang G; Cai K
    Oncotarget; 2017 Sep; 8(37):62312-62329. PubMed ID: 28977947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas.
    Annaratone L; Cascardi E; Vissio E; Sarotto I; Chmielik E; Sapino A; Berrino E; Marchiò C
    Pathobiology; 2020; 87(2):125-142. PubMed ID: 32325459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting Prognostic Effects of Tumor-Infiltrating Lymphocyte Density in Cardia and Non-cardia Gastric Adenocarcinomas.
    Kim HI; Kim SY; Yu JE; Shin SJ; Roh YH; Cheong JH; Hyung WJ; Noh SH; Park CG; Lee HJ
    J Gastric Cancer; 2020 Jun; 20(2):190-201. PubMed ID: 32596002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer.
    Zhang G; Shu Z; Yu J; Li J; Yi P; Wu B; Deng D; Yan S; Li Y; Ren D; Hou Y; Lan C
    Front Immunol; 2024; 15():1341209. PubMed ID: 38352864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer.
    Ohara M; Yamaguchi Y; Matsuura K; Murakami S; Arihiro K; Okada M
    Cancer Immunol Immunother; 2009 Mar; 58(3):441-7. PubMed ID: 18685848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.